Esta tradução está a ser preparada. Entretanto, mostramos temporariamente a versão original em inglês.
Negócios · 11/01/20111 min de leitura
Trials to Verify and Describe Clinical Benefit of Midodrine Hydrochloride; Establishment of Public Docket
Tradução automática local · Idioma original da fonte
Resumo
The Food and Drug Administration (FDA) is announcing the opening of a public docket to provide a forum to facilitate communication regarding the conduct of clinical trials needed to verify and describe the clinical benefit of midodrine hydrochloride (HCl) when used to treat symptomatic orthostatic hypotension.
Idioma original da fonte: Federal Register — Health and Human ServicesAbrir o comunicado original →